Neuromyelitis optica and anti-aquaporin 4 antibody - An overview

Brain and Nerve

Volumn 60, Issue 5, 2008, Pages 527-537

  Misu, Tatsuro ^a   Fujihara, Kazuo ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aquaporin 4; GFAP; Multiple sclerosis; Necrosis; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; AUTOIMMUNITY; BRAIN SLICE; CAUCASIAN; CELL STRAIN HEK293; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; JAPANESE; MOUSE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NONHUMAN; RELAPSE; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; AQUAPORIN 4; ASTROCYTES; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOGLOBULIN G; MICE; MULTIPLE SCLEROSIS; NECROSIS; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 44449134874     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Devic E: Myélite subaiguë compliquée de néurite optique. Bull Med 8: 1033-1034, 1894
2. Gault F: De la neuromyélite optique aiguë [Thesis]. Lyon, 1894
3. Cloys DE, Netsky MG: Neuromyelitis optica. In: Vinken PJ, Bruyn GW (eds), Handbook of Clinical Neurology, vol. 9, Elsevier Science, Amsterdam, 1970, pp426-436
4. Peters G: Neuromyelitis optica. In: Lubarsch O, Henke F, Rosse R (eds), Handbuch der speziellen pathologischen anatomie und histologie, XIII, 11A. Erkrankungen des zentralen nervensystems, Springer, Berlin, 1958, pp630-644
5. No To Shinkei 53: 901-910, 2001
6. Mandler RN, Davis LE, Jeffery DR, Kornfeld M: Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34: 162-168, 1993
7. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114, 1999
8. Poser CM: The epidemiology of multiple sclerosis: a general overview. Ann Neurol 36(Suppl 2): 180-193, 1994
9. Weinshenker BG, Wingerchuk DM, Nakashima I, Fujihara K, Lennon VA: OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5: 110-111, 2006
10. Okinaka S, Reese HH, Katsuki S, Ueki K, Kuroiwa Y, et al: The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand 42(Suppl 19): 68-76, 1966
11. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T: Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 25: 845-851, 1975
12. Kuroiwa Y: Neuromyelitis optica (Devic's disease, Devic's syndrome). In: Koetsier JC, editor. Handbook of clinical neurology, Vol. 47. Demyelinating disease, Elsevier Science, Amsterdam, 1985, pp397-408
13. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, et al: Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40: 569-574, 1996
14. Fukazawa T, Kikuchi S, Miyagishi R, Miyazaki Y, Yabe I, et al: HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301. Mult Scler 12: 19-23, 2006
15. Kira J, Yamasaki K, Horiuchi I, Ohyagi Y, Taniwaki T, et al: Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 166: 53-57, 1999
16. Nakashima I, Fujihara K, Takase S, Itoyama Y: Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 188: 89-94, 1999
17. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, et al: Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 88: 184-189, 1993
18. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, et al: Anti-nuclear antibodies and the optic-spinal form of multiple sclerosis. J Neurol 244: 483-488, 1997
19. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, et al: Pure optic-spinal form of multiple sclerosis in Japan. Brain 125: 2460-2468, 2002
20. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingley DP, et al: Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382-387, 1996
21. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489, 2006
22. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, et al: A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450-1461, 2002
23. Misu T, Kakita A, Fujihara K, Nakashima I, Takahashi H, et al: A comparative neuropathological analysis of Japanese cases of neuromyelitis optica and multiple sclerosis. Neurology 64: A39, 2005
24. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112, 2004
25. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477, 2005
26. Tanaka K, Tani T, Tanaka M, Saida T, Idezuka J, et al: Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 13: 850-855, 2007
27. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, et al: Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. Plos Med 4: e133, 2007
28. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, et al: Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130: 1235-1243, 2007
29. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, et al: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130: 1206-1223, 2007
30. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, et al: Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 210: 307-313, 2006
31. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock Sj, et al: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59: 566-569, 2006
32. Oshio K, Binder DK, Yang B, Schecter S, Verkman AS, et al: Expression of aquaporin water channels in mouse spinal cord. Neuroscience 127: 685-693, 2004
33. Jung J, Bhat R, Preston G, Guggino WB, Baraban JM, et al: Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA 91: 13052-13056, 1994
34. Misu T, Fujihara K, Nakamura M, Murakami, Endo M, et al: Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209: 269-275, 2006
35. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, et al: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 130: 1224-1234, 2007
36. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, et al: Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69: 2221-2231, 2007
37. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, et al: Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63: 964-968, 2006
38. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y: Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 65: 1479-1482, 2005
39. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, et al: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130: 1194-1205, 2007
40. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, et al: Preferential spinal central gray matter involvement in neuromyelitis optica: an MRI study. J Neurol 255: 163-170, 2008
41. Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, et al: Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13: 128-132, 2007
42. Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, et al: Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 255: 305-307, 2008
43. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, et al: Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13: 256-259, 2007
44. Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, et al: Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Multiple Sclerosis 13: 968-974, 2007
45. Mandler RN, Ahmed W, Dencoff JE: Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51: 1219-1220, 1998